SCHEMBL21669124

SCHEMBL21669124

CCOC(=O)c1ccc(N2CC[C@H](OCCOC)C2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 2/20 0.47
LIPC P11150 1/20 0.47
HTT P42858 4/20 0.45
HPGD P15428 2/20 0.45
ACACB O00763 2/20 0.44
ALDH1A1 P00352 5/20 0.43
HSP90AA1 P07900 2/20 0.43
CACNA1B Q00975 1/20 0.43
APBA1 Q02410 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
FDFT1 P37268 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
POLB P06746 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MAPT P10636 1/20 0.42
GAA P10253 1/20 0.41
RAB9A P51151 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21669102 1.00 LIPG (0.47) LIPGLIPCHTTHPGDACACB
SCHEMBL23839397 1.00 LIPG (0.47) LIPGLIPCHTTHPGDACACB
SCHEMBL23839398 0.87 HTT (0.50) HTTHPGDACACBALDH1A1HSP90AA1
SCHEMBL23839396 0.87 HTT (0.50) HTTHPGDACACBALDH1A1HSP90AA1
SCHEMBL21638239 0.85 LIPG (0.53) LIPGLIPCACACB
SCHEMBL21638237 0.85 LIPG (0.53) LIPGLIPCACACB
SCHEMBL21669125 0.85 LIPG (0.53) LIPGLIPCACACB
SCHEMBL6132393 0.85 HTT (0.44) HTTHPGDALDH1A1HSP90AA1CACNA1B
SCHEMBL6132246 0.85 HTT (0.44) HTTHPGDALDH1A1HSP90AA1CACNA1B
SCHEMBL7323856 0.83 ALDH1A1 (0.50) HTTHPGDALDH1A1HSP90AA1CACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11161830-B2 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same FUJIFILM CORPORATION (JP) 2021-11-02 US disclosed
EP-3604301-B1 4-PYRIDONE COMPOUND OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION AND FORMULATION INCLUDING SAME FUJIFILM CORP (JP) 2021-09-22 EP disclosed
EP-3604301-A1 4-PYRIDONE COMPOUND OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION AND FORMULATION INCLUDING SAME FUJIFILM Corporation (JP) 2020-02-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11161830-B2 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same HAVCR2, HBS1L, PHKB LIPG 4820/4885LIPC 3754/4885HTT 3763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.